14-Deacetyl eurylene

Details

Top
Internal ID 4dadfc2d-6e5e-4830-88b9-49396f563529
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Triterpenoids
IUPAC Name [(1S,4R)-4-hydroxy-1-[(2R,5R)-5-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]-4-[(2S,5R)-5-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]butyl] acetate
SMILES (Canonical) CC(=CCCC(C)(C1CCC(O1)(C)C(CCC(C2(CCC(O2)C(C)(CCC=C(C)C)O)C)OC(=O)C)O)O)C
SMILES (Isomeric) CC(=CCC[C@@](C)([C@H]1CC[C@@](O1)(C)[C@@H](CC[C@@H]([C@]2(CC[C@@H](O2)[C@](C)(CCC=C(C)C)O)C)OC(=O)C)O)O)C
InChI InChI=1S/C32H56O7/c1-22(2)12-10-18-29(6,35)26-16-20-31(8,38-26)25(34)14-15-28(37-24(5)33)32(9)21-17-27(39-32)30(7,36)19-11-13-23(3)4/h12-13,25-28,34-36H,10-11,14-21H2,1-9H3/t25-,26-,27-,28+,29+,30+,31+,32-/m1/s1
InChI Key OWELNYSCYCAGMZ-SXSDURSUSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C32H56O7
Molecular Weight 552.80 g/mol
Exact Mass 552.40260412 g/mol
Topological Polar Surface Area (TPSA) 105.00 Ų
XlogP 5.40
Atomic LogP (AlogP) 5.93
H-Bond Acceptor 7
H-Bond Donor 3
Rotatable Bonds 14

Synonyms

Top
CHEMBL303104
[(1S,4R)-4-hydroxy-1-[(2R,5R)-5-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]-4-[(2S,5R)-5-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-2-methyloxolan-2-yl]butyl] acetate

2D Structure

Top
2D Structure of 14-Deacetyl eurylene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9581 95.81%
Caco-2 - 0.7655 76.55%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.6857 68.57%
Subcellular localzation Mitochondria 0.6865 68.65%
OATP2B1 inhibitior - 0.5706 57.06%
OATP1B1 inhibitior + 0.9027 90.27%
OATP1B3 inhibitior + 0.8883 88.83%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior + 0.7837 78.37%
P-glycoprotein inhibitior + 0.7109 71.09%
P-glycoprotein substrate - 0.7610 76.10%
CYP3A4 substrate + 0.6491 64.91%
CYP2C9 substrate - 0.8047 80.47%
CYP2D6 substrate - 0.8649 86.49%
CYP3A4 inhibition - 0.7500 75.00%
CYP2C9 inhibition - 0.6769 67.69%
CYP2C19 inhibition - 0.7250 72.50%
CYP2D6 inhibition - 0.9131 91.31%
CYP1A2 inhibition - 0.7123 71.23%
CYP2C8 inhibition - 0.7828 78.28%
CYP inhibitory promiscuity - 0.7791 77.91%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.8228 82.28%
Carcinogenicity (trinary) Non-required 0.6053 60.53%
Eye corrosion - 0.9730 97.30%
Eye irritation - 0.9072 90.72%
Skin irritation - 0.5948 59.48%
Skin corrosion - 0.9555 95.55%
Ames mutagenesis - 0.6500 65.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7230 72.30%
Micronuclear - 0.8300 83.00%
Hepatotoxicity - 0.5843 58.43%
skin sensitisation - 0.6483 64.83%
Respiratory toxicity - 0.5333 53.33%
Reproductive toxicity + 0.5556 55.56%
Mitochondrial toxicity + 0.6125 61.25%
Nephrotoxicity + 0.5841 58.41%
Acute Oral Toxicity (c) III 0.5229 52.29%
Estrogen receptor binding + 0.6854 68.54%
Androgen receptor binding - 0.4892 48.92%
Thyroid receptor binding - 0.4881 48.81%
Glucocorticoid receptor binding + 0.6810 68.10%
Aromatase binding + 0.6769 67.69%
PPAR gamma + 0.5995 59.95%
Honey bee toxicity - 0.6178 61.78%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.6300 63.00%
Fish aquatic toxicity + 0.9533 95.33%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.93% 97.25%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.81% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.79% 96.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 93.95% 94.45%
CHEMBL218 P21554 Cannabinoid CB1 receptor 93.46% 96.61%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.13% 97.09%
CHEMBL2581 P07339 Cathepsin D 90.86% 98.95%
CHEMBL233 P35372 Mu opioid receptor 90.18% 97.93%
CHEMBL340 P08684 Cytochrome P450 3A4 87.14% 91.19%
CHEMBL4051 P13569 Cystic fibrosis transmembrane conductance regulator 87.05% 95.71%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 86.65% 92.62%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 86.53% 98.75%
CHEMBL284 P27487 Dipeptidyl peptidase IV 85.91% 95.69%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 85.27% 91.07%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 84.69% 100.00%
CHEMBL3359 P21462 Formyl peptide receptor 1 84.48% 93.56%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 84.30% 96.77%
CHEMBL2413 P32246 C-C chemokine receptor type 1 84.11% 89.50%
CHEMBL4227 P25090 Lipoxin A4 receptor 84.10% 100.00%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.01% 95.89%
CHEMBL2179 P04062 Beta-glucocerebrosidase 83.92% 85.31%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 83.60% 97.14%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 83.53% 92.88%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 83.37% 96.95%
CHEMBL3060 Q9Y345 Glycine transporter 2 83.05% 99.17%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 82.88% 95.50%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.44% 89.00%
CHEMBL4005 P42336 PI3-kinase p110-alpha subunit 81.71% 97.47%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.65% 100.00%
CHEMBL1293316 Q9HBX9 Relaxin receptor 1 81.52% 82.50%
CHEMBL3430907 Q96GD4 Aurora kinase B/Inner centromere protein 81.42% 97.50%
CHEMBL237 P41145 Kappa opioid receptor 81.33% 98.10%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.23% 85.14%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 81.22% 95.89%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 81.13% 89.05%
CHEMBL1795139 Q8IU80 Transmembrane protease serine 6 81.00% 98.33%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 80.50% 96.90%

Cross-Links

Top
PubChem 11786187
NPASS NPC3852
LOTUS LTS0126627
wikiData Q105201954